Details for New Drug Application (NDA): 201762
✉ Email this page to a colleague
The generic ingredient in QUETIAPINE FUMARATE is quetiapine fumarate. There are fifty-three drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the quetiapine fumarate profile page.
Summary for 201762
Tradename: | QUETIAPINE FUMARATE |
Applicant: | Actavis Grp Ptc |
Ingredient: | quetiapine fumarate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 201762
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | Feb 27, 2013 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Feb 27, 2013 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Feb 27, 2013 | TE: | RLD: | No |
Complete Access Available with Subscription